+
Open data
-
Basic information
Entry | Database: EMDB / ID: EMD-21212 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | Structure of CD20 in complex with rituximab Fab | |||||||||
![]() | Sharpened map, used for figure making and model building. | |||||||||
![]() |
| |||||||||
![]() | MS4A1 / CD20 / human / Rituximab / therapeutic / antibody / IMMUNE SYSTEM | |||||||||
Function / homology | ![]() store-operated calcium entry / calcium ion import into cytosol / positive regulation of calcium ion import across plasma membrane / epidermal growth factor receptor binding / immunoglobulin binding / B cell activation / humoral immune response / B cell proliferation / plasma membrane raft / B cell differentiation ...store-operated calcium entry / calcium ion import into cytosol / positive regulation of calcium ion import across plasma membrane / epidermal growth factor receptor binding / immunoglobulin binding / B cell activation / humoral immune response / B cell proliferation / plasma membrane raft / B cell differentiation / B cell receptor signaling pathway / protein tetramerization / response to bacterium / MHC class II protein complex binding / cell surface receptor signaling pathway / external side of plasma membrane / cell surface / extracellular space / extracellular exosome / nucleoplasm / identical protein binding / plasma membrane Similarity search - Function | |||||||||
Biological species | ![]() | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 3.3 Å | |||||||||
![]() | Rohou A | |||||||||
![]() | ![]() Title: Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab. Authors: Lionel Rougé / Nancy Chiang / Micah Steffek / Christine Kugel / Tristan I Croll / Christine Tam / Alberto Estevez / Christopher P Arthur / Christopher M Koth / Claudio Ciferri / Edward ...Authors: Lionel Rougé / Nancy Chiang / Micah Steffek / Christine Kugel / Tristan I Croll / Christine Tam / Alberto Estevez / Christopher P Arthur / Christopher M Koth / Claudio Ciferri / Edward Kraft / Jian Payandeh / Gerald Nakamura / James T Koerber / Alexis Rohou / ![]() ![]() Abstract: Cluster of differentiation 20 (CD20) is a B cell membrane protein that is targeted by monoclonal antibodies for the treatment of malignancies and autoimmune disorders but whose structure and function ...Cluster of differentiation 20 (CD20) is a B cell membrane protein that is targeted by monoclonal antibodies for the treatment of malignancies and autoimmune disorders but whose structure and function are unknown. Rituximab (RTX) has been in clinical use for two decades, but how it activates complement to kill B cells remains poorly understood. We obtained a structure of CD20 in complex with RTX, revealing CD20 as a compact double-barrel dimer bound by two RTX antigen-binding fragments (Fabs), each of which engages a composite epitope and an extensive homotypic Fab:Fab interface. Our data suggest that RTX cross-links CD20 into circular assemblies and lead to a structural model for complement recruitment. Our results further highlight the potential relevance of homotypic Fab:Fab interactions in targeting oligomeric cell-surface markers. | |||||||||
History |
|
-
Structure visualization
Movie |
![]() |
---|---|
Structure viewer | EM map: ![]() ![]() ![]() |
Supplemental images |
-
Downloads & links
-EMDB archive
Map data | ![]() | 105.5 MB | ![]() | |
---|---|---|---|---|
Header (meta data) | ![]() ![]() | 21.5 KB 21.5 KB | Display Display | ![]() |
FSC (resolution estimation) | ![]() | 10.9 KB | Display | ![]() |
Images | ![]() | 150 KB | ||
Masks | ![]() | 113.6 MB | ![]() | |
Filedesc metadata | ![]() | 6.9 KB | ||
Others | ![]() ![]() | 13 MB 13 MB | ||
Archive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
Related structure data | ![]() 6vjaMC M: atomic model generated by this map C: citing same article ( |
---|---|
Similar structure data |
-
Links
EMDB pages | ![]() ![]() |
---|
-
Map
File | ![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Sharpened map, used for figure making and model building. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 1 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
CCP4 map header:
|
-Supplemental data
-Mask #1
File | ![]() | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: FSC map 1
File | emd_21212_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | FSC map 1 | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: FSC map 2
File | emd_21212_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | FSC map 2 | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-
Sample components
-Entire : CD20 in complex with rituximab Fab
Entire | Name: CD20 in complex with rituximab Fab |
---|---|
Components |
|
-Supramolecule #1: CD20 in complex with rituximab Fab
Supramolecule | Name: CD20 in complex with rituximab Fab / type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1-#3 |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 135 KDa |
-Macromolecule #1: B-lymphocyte antigen CD20
Macromolecule | Name: B-lymphocyte antigen CD20 / type: protein_or_peptide / ID: 1 / Number of copies: 2 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 31.320789 KDa |
Recombinant expression | Organism: ![]() |
Sequence | String: MGSTQSFFMR ESKTLGAVQI MNGLFHIALG GLLMIPAGIY APICVTVWYP LWGGIMYIIS GSLLAATEKN SRKCLVKGKM IMNSLSLFA AISGMILSIM DILNIKISHF LKMESLNFIR AHTPYINIYN CEPANPSEKN SPSTQYCYSI QSLFLGILSV M LIFAFFQE ...String: MGSTQSFFMR ESKTLGAVQI MNGLFHIALG GLLMIPAGIY APICVTVWYP LWGGIMYIIS GSLLAATEKN SRKCLVKGKM IMNSLSLFA AISGMILSIM DILNIKISHF LKMESLNFIR AHTPYINIYN CEPANPSEKN SPSTQYCYSI QSLFLGILSV M LIFAFFQE LVIAGIVENE WKRTCSRPKS NIVLLSAEEK KEQTIEIKEE VVGLTETSSQ PKNEEDIEII PIQEEEEEET ET NFPEPPQ DQESSPIEND SSPGNSENLY FQGHHHHHHH H UniProtKB: B-lymphocyte antigen CD20 |
-Macromolecule #2: Rituximab Fab heavy chain
Macromolecule | Name: Rituximab Fab heavy chain / type: protein_or_peptide / ID: 2 / Number of copies: 2 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 23.733541 KDa |
Recombinant expression | Organism: ![]() ![]() |
Sequence | String: QVQLQQPGAE LVKPGASVKM SCKASGYTFT SYNMHWVKQT PGRGLEWIGA IYPGNGDTSY NQKFKGKATL TADKSSSTAY MQLSSLTSE DSAVYYCARS TYYGGDWYFN VWGAGTTVTV SAASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT V SWNSGALT ...String: QVQLQQPGAE LVKPGASVKM SCKASGYTFT SYNMHWVKQT PGRGLEWIGA IYPGNGDTSY NQKFKGKATL TADKSSSTAY MQLSSLTSE DSAVYYCARS TYYGGDWYFN VWGAGTTVTV SAASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT V SWNSGALT SGVHTFPAVL QSSGLYSLSS VVTVPSSSLG TQTYICNVNH KPSNTKVDKK VEPKSC |
-Macromolecule #3: Rituximab Fab light chain
Macromolecule | Name: Rituximab Fab light chain / type: protein_or_peptide / ID: 3 / Number of copies: 2 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 23.078623 KDa |
Recombinant expression | Organism: ![]() ![]() |
Sequence | String: QIVLSQSPAI LSASPGEKVT MTCRASSSVS YIHWFQQKPG SSPKPWIYAT SNLASGVPVR FSGSGSGTSY SLTISRVEAE DAATYYCQQ WTSNPPTFGG GTKLEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ E SVTEQDSK ...String: QIVLSQSPAI LSASPGEKVT MTCRASSSVS YIHWFQQKPG SSPKPWIYAT SNLASGVPVR FSGSGSGTSY SLTISRVEAE DAATYYCQQ WTSNPPTFGG GTKLEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ E SVTEQDSK DSTYSLSSTL TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC |
-Macromolecule #4: CHOLESTEROL HEMISUCCINATE
Macromolecule | Name: CHOLESTEROL HEMISUCCINATE / type: ligand / ID: 4 / Number of copies: 6 / Formula: Y01 |
---|---|
Molecular weight | Theoretical: 486.726 Da |
Chemical component information | ![]() ChemComp-Y01: |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
![]() | single particle reconstruction |
Aggregation state | particle |
-
Sample preparation
Concentration | 2 mg/mL | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Buffer | pH: 7.5 Component:
| ||||||||||||
Grid | Model: Quantifoil, UltrAuFoil, R1.2/1.3 / Material: GOLD / Mesh: 300 / Support film - Material: CARBON / Support film - topology: HOLEY | ||||||||||||
Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 277 K / Instrument: FEI VITROBOT MARK IV / Details: 5s blot time. |
-
Electron microscopy
Microscope | FEI TITAN KRIOS |
---|---|
Specialist optics | Energy filter - Name: GIF Bioquantum / Energy filter - Slit width: 20 eV |
Image recording | Film or detector model: GATAN K2 QUANTUM (4k x 4k) / Detector mode: COUNTING / Digitization - Frames/image: 1-40 / Number grids imaged: 3 / Number real images: 24743 / Average exposure time: 10.0 sec. / Average electron dose: 53.0 e/Å2 |
Electron beam | Acceleration voltage: 300 kV / Electron source: ![]() |
Electron optics | C2 aperture diameter: 70.0 µm / Calibrated magnification: 58906 / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal magnification: 165000 |
Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN |
Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
+
Image processing
-Atomic model buiding 1
Initial model | PDB ID: Chain - Source name: PDB / Chain - Initial model type: experimental model |
---|---|
Details | Atomic model for CD20 was built ab initio and manually in COOT. It was then re-built using ISOLDE, and finally refined in Phenix. |
Refinement | Space: REAL / Protocol: AB INITIO MODEL |
Output model | ![]() PDB-6vja: |
-Atomic model buiding 2
Details | The X-ray crystallographic atomic model for Rituximab Fab was rigid-body fit into the map, modified using Cootand ISOLDE, and refined with Phenix |
---|---|
Refinement | Space: REAL / Protocol: FLEXIBLE FIT |
Output model | ![]() PDB-6vja: |